172 related articles for article (PubMed ID: 17484928)
1. Management of non-retroperitoneal residual germ cell tumor masses.
Katz MH; McKiernan JM
Urol Clin North Am; 2007 May; 34(2):235-43; abstract x. PubMed ID: 17484928
[TBL] [Abstract][Full Text] [Related]
2. Treatment of nonretroperitoneal residual germ cell tumor masses.
Katz MH; McKiernan JM
Urol Oncol; 2005; 23(6):431-9. PubMed ID: 16301123
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
Shayegan B; Carver BS; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
BJU Int; 2007 May; 99(5):993-7. PubMed ID: 17437432
[TBL] [Abstract][Full Text] [Related]
4. Nonseminomatous germ cell tumors: assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis.
Besse B; Grunenwald D; Fléchon A; Caty A; Chevreau C; Culine S; Théodore C; Fizazi K
J Thorac Cardiovasc Surg; 2009 Feb; 137(2):448-52. PubMed ID: 19185168
[TBL] [Abstract][Full Text] [Related]
5. Management of residual non-retroperitoneal disease following chemotherapy for germ cell tumor.
Sadeghi N; Badalato GM; Kates M; McKiernan JM
Urol Oncol; 2011; 29(6):837-41. PubMed ID: 21489835
[TBL] [Abstract][Full Text] [Related]
6. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.
Carver BS; Shayegan B; Eggener S; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
J Clin Oncol; 2007 Oct; 25(28):4365-9. PubMed ID: 17906201
[TBL] [Abstract][Full Text] [Related]
7. The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor.
Dash A; Carver BS; Stasi J; Bajorin DF; Motzer RJ; Bosl GJ; Sheinfeld J
Cancer; 2008 Feb; 112(4):800-5. PubMed ID: 18172902
[TBL] [Abstract][Full Text] [Related]
8. Testicular tumors: residual retroperitoneal mass surgery after chemotherapy;Is it possible to predict their histology?
Medina-Polo J; Martínez-Silva V; Domínguez-Esteban M; de la Rosa-Kehrmann F; Villacampa-Aubá F; Castellano-Gauna D; Díaz-González R
Arch Esp Urol; 2011 Sep; 64(7):611-9. PubMed ID: 21965259
[TBL] [Abstract][Full Text] [Related]
9. Repeat retroperitoneal lymph-node dissection after chemotherapy for metastatic testicular germ cell tumour.
Willis SF; Winkler M; Savage P; Seckl MJ; Christmas TJ
BJU Int; 2007 Oct; 100(4):809-12. PubMed ID: 17711512
[TBL] [Abstract][Full Text] [Related]
10. Germ cell tumors with sarcomatous components: a clinicopathologic and immunohistochemical study of 46 cases.
Malagón HD; Valdez AM; Moran CA; Suster S
Am J Surg Pathol; 2007 Sep; 31(9):1356-62. PubMed ID: 17721191
[TBL] [Abstract][Full Text] [Related]
11. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
Ondrus D; Ondrusova M; Hornak M; Matoska J
Neoplasma; 2007; 54(5):437-42. PubMed ID: 17688374
[TBL] [Abstract][Full Text] [Related]
12. The role of adjunctive postchemotherapy surgery for nonseminomatous germ-cell tumors: current concepts and controversies.
Sheinfeld J
Semin Urol Oncol; 2002 Nov; 20(4):262-71. PubMed ID: 12489059
[TBL] [Abstract][Full Text] [Related]
13. Incidence of disease outside modified retroperitoneal lymph node dissection templates in clinical stage I or IIA nonseminomatous germ cell testicular cancer.
Eggener SE; Carver BS; Sharp DS; Motzer RJ; Bosl GJ; Sheinfeld J
J Urol; 2007 Mar; 177(3):937-42; discussion 942-3. PubMed ID: 17296380
[TBL] [Abstract][Full Text] [Related]
14. Management of advanced germ-cell tumors of the testis.
Fléchon A; Rivoire M; Droz JP
Nat Clin Pract Urol; 2008 May; 5(5):262-76. PubMed ID: 18398406
[TBL] [Abstract][Full Text] [Related]
15. Retroperitoneal lymph node dissection after chemotherapy.
Winter C; Raman JD; Sheinfeld J; Albers P
BJU Int; 2009 Nov; 104(9 Pt B):1404-12. PubMed ID: 19840021
[TBL] [Abstract][Full Text] [Related]
16. Primary retroperitoneal lymph node dissection in patients with clinical stage IS testis cancer.
Williams SB; Steele GS; Richie JP
J Urol; 2009 Dec; 182(6):2716-20. PubMed ID: 19836777
[TBL] [Abstract][Full Text] [Related]
17. Recurrence in nonseminomatous germ cell testis tumor patients with no viable tumor at postchemotherapy retroperitoneal lymph node dissection.
Spiess PE; Tannir NM; Brown GA; Liu P; Tu SM; Evans JG; Pisters LL
Urology; 2007 Dec; 70(6):1173-8. PubMed ID: 18158041
[TBL] [Abstract][Full Text] [Related]
18. Outcome of patients with residual germ cell or non-germ cell malignancy after resection of primary mediastinal nonseminomatous germ cell cancer.
Schneider BP; Kesler KA; Brooks JA; Yiannoutsos C; Einhorn LH
J Clin Oncol; 2004 Apr; 22(7):1195-200. PubMed ID: 15051766
[TBL] [Abstract][Full Text] [Related]
19. Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer.
Stephenson AJ; Bosl GJ; Motzer RJ; Bajorin DF; Stasi JP; Sheinfeld J
J Clin Oncol; 2007 Dec; 25(35):5597-602. PubMed ID: 18065732
[TBL] [Abstract][Full Text] [Related]
20. Survival after resection for metastatic testicular nonseminomatous germ cell cancer to the lung or mediastinum.
Kesler KA; Kruter LE; Perkins SM; Rieger KM; Sullivan KJ; Runyan ML; Brown JW; Einhorn LH
Ann Thorac Surg; 2011 Apr; 91(4):1085-93; discussion 1093. PubMed ID: 21440128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]